ストックスクリーナーアプリを入手
3.51
0.28%
-0.01
前日終値:
$3.52
開ける：
$3.49
24時間の取引高:
1,805
Relative Volume:
0.02
時価総額：
$63.62M
収益：
-
当期純損益:
-
株価収益率:
-4.9492
EPS:
-0.7092
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-8.59%
1か月 パフォーマンス:
-26.26%
6か月 パフォーマンス:
-12.47%
1年 パフォーマンス:
+228.04%
1日の値動き範囲:
$3.4887
$3.61
1週間の範囲:
$3.47
$3.8596
52週間の値動き範囲:
$1.001
$7.00
Alterity Therapeutics Ltd Adr Stock (ATHE) Company Profile
ATHE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATHE
Alterity Therapeutics Ltd Adr
|
3.51 | 63.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alterity Therapeutics Ltd Adr Stock (ATHE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-03 | ダウングレード | The Benchmark Company | Speculative Buy → Hold |
| 2024-12-12 | 開始されました | Maxim Group | Buy |
Alterity Therapeutics Ltd Adr (ATHE) 最新ニュース
Alterity Therapeutics Ltd (ADR) trading halted, news pending - MSN
ASX Stock Market News | Australian Shares - new.smallcaps.com.au
Antalpha Platform Holding Company (NASDAQ:ANTA) Short Interest Update - Defense World
Contrasting Alterity Therapeutics (NASDAQ:ATHE) & BioHarvest Sciences (NASDAQ:BHST) - Defense World
CapEx per share of Alterity Therapeutics Ltd. Sponsored ADR – NASDAQ:ATHE - TradingView
Alterity Therapeutics stock rises after positive MSA trial data presented at conference - Investing.com
Alterity Therapeutics (NASDAQ:ATHE) Shares Down 0.5% – What’s Next? - Defense World
Alterity Therapeutics presents ATH434-201 Phase 2 data - TipRanks
ASX recovers to shed just 0.13pc as healthcare and gold drags - Geelong Advertiser
Alterity Therapeutics raises A$20M in strategic placement - MSN
ATHE: A Tale of Ups & Downs – 63.16% gain in 6 Months, 42.35% in 30 Days - investchronicle.com
SMCI’s Market Flip-Flop: Exploring the Volatility of 2025 Performance - investchronicle.com
Alterity CEO to provide corporate update on ATH434 development - Investing.com
Alterity Therapeutics highlighted at MSA Congress - Investing.com
Alterity Therapeutics reports Phase 2 data at MSA Congress - Investing.com
Alterity shares new phase 2 data on MSA treatment - Investing.com India
Alterity Therapeutics announces regulatory notice - Investing.com
Alterity Therapeutics announces compliance notice - Investing.com
Alterity secures funding to advance MSA drug development - Investing.com
Alterity Therapeutics announces trading halt - Investing.com
Alterity Therapeutics reports compliance with Takeovers Panel - Investing.com
Alterity Therapeutics announces securities notice - Investing.com
ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead
Most active stocks: US stocks with the highest trading volume today - Yahoo
symbol__ Stock Quote Price and Forecast - CNN
Appendix 4E & Annual Report 2023SEC.gov - SEC.gov
Biotech Stocks: Longevity Company Stocks - Investing.com
Alterity Therapeutics LtdADR (ATHE) News, Articles, Events & Latest Updates - Stocktwits
Alterity Therapeutics Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology - Investing.com India
Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) - PR Newswire
Ernexa Therapeutics (ERNA) Short Interest Ratio and Volume 2025 - MarketBeat
Trading Halts Explained - MarketBeat
Biggest Stock LosersToday’s Biggest Percentage Decliners - MarketBeat
ATHE Pivot Points, Technical Analysis and Moving AveragesAlterity Therapeutics LtdAdr Technicals - CMLviz
Genprex (GNPX) Short Interest Ratio and Volume 2025 - MarketBeat
Integrated BioPharma (INBP) Short Interest Ratio and Volume 2025 - MarketBeat
ESSA Pharma (EPIX) Short Interest Ratio and Volume 2025 - MarketBeat
ATHEAlterity Therapeutics Ltd Latest Stock News & Market Updates - Stock Titan
Maxim Group Analyst Recommendations & Stock Picks - MarketBeat
ATHE Stock Price | Alterity Therapeutics Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
ATH Stock Price and Chart — ASX:ATH - TradingView
ATHE Stock Price and Chart — NASDAQ:ATHE - TradingView
Most Volatile Stocks, What Investors Need to Know - MarketBeat
How Investors Can Identify and Successfully Trade Gap-Down Stocks - MarketBeat
What Investors Need to Know to Beat the Market - MarketBeat
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
Alterity Therapeutics Ltd Adr (ATHE) 財務データ
Alterity Therapeutics Ltd Adr (ATHE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):